Literature DB >> 9358080

A baboon model for hematologic studies of cardiopulmonary bypass.

Y Hiramatsu1, N Gikakis, J H Gorman, M M Khan, C E Hack, H T Velthuis, L Sun, C Marcinkiewicz, A K Rao, S Niewiarowski, R W Colman, L H Edmunds, H L Anderson.   

Abstract

Objective investigation of new inhibitors of blood protein or cellular systems that are activated during cardiopulmonary bypass (CPB) is impeded by the absence of a satisfactory animal model. Because most baboon hematologic proteins immunologically cross-react with those used for human assays, we developed a robust, reusable baboon model of CPB. Blood samples were obtained from adult baboons at six time intervals before, during, and after 60 minutes of partial CPB at 37 degrees C with peripheral cannulas. Both membrane (n = 7) and bubble oxygenators (n = 7) were investigated. We measured platelet and white blood cell counts; platelet response to adenosine diphosphate and release of beta-thromboglobulin; fibrinopeptide A, prothrombin fragment F1.2, thrombin-antithrombin complex, D-dimer, and plasmin-antiplasmin complex; activated complement (C3b/c and C4b/c); elastase-alpha1 proteinase inhibitor complex; and bleeding times. Adherent glycoprotein IIIa antigen in Triton X-100 washes of the perfusion circuit was also measured. Markers of baboon platelet, complement, and neutrophil activation and thrombosis significantly increased during CPB with bubble oxygenator systems but did not change appreciably in membrane oxygenator circuits. Markers of fibrinolysis, D-dimer, and plasmin-antiplasmin complex did not change with either oxygenator. The baboon model of CPB, when a bubble oxygenator is used, is a robust, reusable animal model for evaluating inhibitors of platelet, complement, and neutrophil activation and thrombosis during and after CPB.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9358080     DOI: 10.1016/s0022-2143(97)90041-x

Source DB:  PubMed          Journal:  J Lab Clin Med        ISSN: 0022-2143


  5 in total

Review 1.  Modern complement analysis.

Authors:  Michael Kirschfink; Tom E Mollnes
Journal:  Clin Diagn Lab Immunol       Date:  2003-11

2.  Anticoagulant therapy during cardiopulmonary bypass.

Authors:  Maryam Yavari; Richard C Becker
Journal:  J Thromb Thrombolysis       Date:  2008-10-19       Impact factor: 2.300

3.  Pediatric cardiopulmonary bypass adaptations for long-term survival of baboons undergoing pulmonary artery replacement.

Authors:  Carrie Whittaker; Gary Grist; Arthur Bert; Kathleen Brasky; Stacy Neighbors; Christopher McFall; Stephen L Hilbert; William B Drake; Michael Cromwell; Barbara Mueller; Gary K Lofland; Richard A Hopkins
Journal:  J Extra Corpor Technol       Date:  2010-09

4.  Oxygenator Is the Main Responsible for Leukocyte Activation in Experimental Model of Extracorporeal Circulation: A Cautionary Tale.

Authors:  Alessio Rungatscher; Maddalena Tessari; Chiara Stranieri; Erika Solani; Daniele Linardi; Elisabetta Milani; Alessio Montresor; Flavia Merigo; Beatrice Salvetti; Tiziano Menon; Giuseppe Faggian
Journal:  Mediators Inflamm       Date:  2015-05-04       Impact factor: 4.711

5.  A novel minimal invasive mouse model of extracorporeal circulation.

Authors:  Shuhua Luo; Menglin Tang; Lei Du; Lina Gong; Jin Xu; Youwen Chen; Yabo Wang; Ke Lin; Qi An
Journal:  Mediators Inflamm       Date:  2015-01-29       Impact factor: 4.711

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.